TY  - JOUR
AU  - Trujillo-Santos, Javier
AU  - Farge-Bancel, Dominique
AU  - Pedrajas, Jose Maria
AU  - Gomez-Cuervo, Covadonga
AU  - Ballaz, Aitor
AU  - Braester, Andrei
AU  - Mahe, Isabelle
AU  - Villalobos, Aurora
AU  - Porras, Jose Antonio
AU  - Monreal, Manuel
PY  - 2022
DO  - 10.1002/rth2.12736
UR  - http://hdl.handle.net/10668/22528
T2  - Research and practice in thrombosis and haemostasis
AB  - Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. The objective of the RIETECAT study was to compare the long-term effectiveness and safety of enoxaparin versus dalteparin or...
LA  - en
PB  - Wiley-Blackwell Publishing
KW  - LMWH
KW  - Cancer
KW  - Cohort
KW  - Dalteparin
KW  - Enoxaparin
KW  - Recurrences
KW  - Tinzaparin
KW  - Venous thromboembolism
KW  - Proportional Hazards Models
KW  - Propensity Score
KW  - Secondary Prevention
KW  - Hemorrhage
TI  - Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study.
TY  - research article
VL  - 6
ER  -